35.84

2.37% 0.8597

Veracyte Inc (VCYT)

Overview News Price History Option Chain Financials Discussions Forecast

Veracyte Inc stock is traded at $35.84, with a volume of 380.41K. It is up +2.37% in the last 24 hours and up +9.04% over the past month.

Previous Close:

$34.98

Open:

$34.77

24h Volume:

380.41K

Relative Volume:

0.45

Market Cap:

$1.74B

Revenue:

$361.05M

Net Income/Loss:

$-74.40M

P/E Ratio:

-89.60

EPS:

-0.4

Net Cash Flow:

$34.26M

1W Performance:

+4.16%

1M Performance:

+9.04%

6M Performance:

+75.97%

1Y Performance:

+46.40%

1-Day Range:

$34.41

$35.87

1-Week Range:

$33.56

$35.87

52-Week Range:

$18.61

$35.87

Veracyte Inc Stock (VCYT) Company Profile

Name

Veracyte Inc

Sector

Healthcare (1181)

Industry

Diagnostics & Research (57)

Phone

(650) 243-6300

Address

6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Employee

Twitter

@veracyte

Next Earnings Date

2024-11-06

Latest SEC Filings

VCYT's Discussions on Twitter

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Nov-18-21	Resumed	Goldman	Buy
Jun-15-21	Initiated	Raymond James	Outperform
Feb-18-21	Resumed	Needham	Buy
Jan-28-21	Initiated	Truist	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-09-20	Initiated	Morgan Stanley	Underweight
Jul-31-19	Initiated	Lake Street	Buy
Jul-02-19	Initiated	Needham	Buy
Nov-29-18	Downgrade	Janney	Buy → Neutral
Oct-31-18	Upgrade	Janney	Neutral → Buy
Nov-07-17	Downgrade	Janney	Buy → Neutral
Nov-07-17	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-31-17	Resumed	BTIG Research	Buy
Nov-14-16	Resumed	Leerink Partners	Outperform
Dec-18-15	Initiated	Cantor Fitzgerald	Buy
Jun-11-15	Reiterated	Leerink Partners	Outperform
Nov-26-13	Initiated	William Blair	Outperform

View All

Veracyte Inc Stock (VCYT) Latest News

07:51 AM

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings - GuruFocus.com

07:51 AM

Nov 04, 2024

New York State Common Retirement Fund Trims Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 04, 2024

Nov 03, 2024

Assenagon Asset Management S.A. Raises Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 03, 2024

Allspring Global Investments Holdings LLC Trims Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Nov 03, 2024

Nov 01, 2024

127,190 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Rice Hall James & Associates LLC - MarketBeat

Nov 01, 2024

Oct 30, 2024

Veracyte to Participate in Upcoming Investor Conferences - The Bakersfield Californian

Oct 30, 2024

AMI Asset Management Corp Sells 19,514 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Oct 30, 2024

Blue Trust Inc. Increases Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Oct 30, 2024

Veracyte (VCYT) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024

Oct 24, 2024

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Boa - GuruFocus.com

Oct 24, 2024

Oct 19, 2024

Veracyte, Inc. (NASDAQ:VCYT) Receives $34.80 Average Price Target from Analysts - Defense World

Oct 19, 2024

Oct 18, 2024

Veracyte (NASDAQ:VCYT) Now Covered by UBS Group - Defense World

Oct 18, 2024

Oct 17, 2024

Veracyte (NASDAQ:VCYT) Price Target Raised to $40.00 at Leerink Partners - MarketBeat

Oct 17, 2024

Oct 16, 2024

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 - Business Wire

Oct 16, 2024

Veracyte started at buy by UBS, MRD platform cited - MSN

Oct 16, 2024

Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) PT at $34.80 - MarketBeat

Oct 16, 2024

Veracyte stock outlook improves as UBS initiates coverage, anticipating robust growth - Investing.com

Oct 16, 2024

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount? - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Analysts review Veracyte Inc’s rating - Knox Daily

Oct 15, 2024

Financial Metrics Unveiled: Veracyte Inc (VCYT)’s Key Ratios in the Spotlight - The Dwinnex

Oct 15, 2024

Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Exchange Traded Concepts LLC - MarketBeat

Oct 15, 2024

Oct 14, 2024

What is Veracyte Inc (VCYT) Stock Return on Shareholders’ Capital? - SETE News

Oct 14, 2024

The Manufacturers Life Insurance Company Acquires 2,135 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Oct 14, 2024

Oct 12, 2024

Cubist Systematic Strategies LLC Trims Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Oct 12, 2024

Oct 11, 2024

Selling Buzz: Veracyte Inc [VCYT] Director JONES EVAN/ FA sells 5,173 shares of the company - Knox Daily

Oct 11, 2024

How to Find Strong Buy Medical Stocks Using the Zacks Rank - Yahoo Finance

Oct 11, 2024

Guggenheim Initiates Coverage of Veracyte (VCYT) with Buy Recommendation - Nasdaq

Oct 11, 2024

Oct 10, 2024

Taking the lead: Veracyte Inc (VCYT) - SETE News

Oct 10, 2024

Breaking Down Veracyte: 4 Analysts Share Their Views - Benzinga

Oct 10, 2024

Ratio Revelations: Veracyte Inc (VCYT)’s Financial Metrics in the Spotlight - The Dwinnex

Oct 10, 2024

Veracyte (NASDAQ:VCYT) Research Coverage Started at Guggenheim - MarketBeat

Oct 10, 2024

Investors push Veracyte (NASDAQ:VCYT) 5.5% lower this week, company's increasing losses might be to blame - Simply Wall St

Oct 10, 2024

Oct 09, 2024